申请人:TAKEDA PHARMACEUTICAL COMPANY LIMITED
公开号:US20160060273A1
公开(公告)日:2016-03-03
Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.
提供的是以下式子(1)所代表的化合物或其盐,具有SSTR5拮抗作用:其中每个符号的定义与说明书中相同。